A mixture of good and bad news came out recently from the COVID-19 vaccine development. US Moderna Inc came up with positive news that its vaccine during the phase 1 trial is producing neutralizing antibodies to the virus and appears safe with the exception of a few volunteers displaying side effect of flu symptoms after vaccination. Phase 2 trial will also try to find the best dosage for administration and will start soon in May'20 and Phase 3 trial on efficacy and safety using larger sample population will commence in July'20. This is good news for all, in particularly, the battered travel and hospitality sector.

However, the Oxford vaccine in development in UK seems to have hit a wall. From the animal testing, all the monkeys vaccinated were eventually infected despite developing some antibodies to the virus. The slightly positive news is that it appears that vaccinated monkeys